Trials / Completed
CompletedNCT00147160
Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents
Phase II Study of the Combination of Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents at Diagnosis or in Relapse
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 87 (estimated)
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris · Academic / Other
- Sex
- All
- Age
- 4 Years – 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether the combination of Temozolomide and Cisplatinum is effective in the treatment of malignant glial tumours of children and adolescents
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Temozolomide, Cisplatinum |
Timeline
- Start date
- 2003-10-01
- Primary completion
- 2006-07-01
- Completion
- 2007-12-01
- First posted
- 2005-09-07
- Last updated
- 2012-04-11
Locations
2 sites across 2 countries: France, United Kingdom
Source: ClinicalTrials.gov record NCT00147160. Inclusion in this directory is not an endorsement.